Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

PD-1hi CXCR5- T peripheral helper cells promote B cells responses in lupus via MAF and IL-21.

Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, Muise E, Zhang KX, Arazi A, Keras G, Li ZJ, Qu Y, Gurish MF, Petri M, Buyon JP, Putterman C, Wofsy D, James JA, Guthridge JM, Diamond B, Anolik JH, Mackey MF, Alves SE, Nigrovic PA, Costenbader KH, Brenner MB, Lederer JA, Rao DA.

JCI Insight. 2019 Sep 19. pii: 130062. doi: 10.1172/jci.insight.130062. [Epub ahead of print]

2.

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network.

Nat Immunol. 2019 Oct;20(10):1404. doi: 10.1038/s41590-019-0473-3.

PMID:
31409923
3.

Circulating CXCR5-PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes.

Ekman I, Ihantola EL, Viisanen T, Rao DA, Näntö-Salonen K, Knip M, Veijola R, Toppari J, Ilonen J, Kinnunen T.

Diabetologia. 2019 Sep;62(9):1681-1688. doi: 10.1007/s00125-019-4936-8. Epub 2019 Jul 3.

4.

Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment.

Doddapaneni BS, Al-Fatease AM, Rao DA, Alani AWG.

J Control Release. 2019 Aug 10;307:272-281. doi: 10.1016/j.jconrel.2019.06.036. Epub 2019 Jun 28.

PMID:
31260753
5.

The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network.

Nat Immunol. 2019 Jul;20(7):902-914. doi: 10.1038/s41590-019-0398-x. Epub 2019 Jun 17. Erratum in: Nat Immunol. 2019 Aug 13;:.

PMID:
31209404
6.

The rise of peripheral T helper cells in autoimmune disease.

Rao DA.

Nat Rev Rheumatol. 2019 Aug;15(8):453-454. doi: 10.1038/s41584-019-0241-7. No abstract available.

PMID:
31138905
7.

HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness.

Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, Rozo C, Sokhi UK, Shanaj S, Oliver DJ, Echeverria AP, DiCarlo EF, Brenner MB, Bykerk VP, Goodman SM, Raychaudhuri S, Rätsch G, Ivashkiv LB, Donlin LT.

Sci Transl Med. 2019 May 8;11(491). pii: eaau8587. doi: 10.1126/scitranslmed.aau8587.

8.

Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry.

Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, Goodman SM, Tabechian D, Hughes LB, Salomon-Escoto K, Watts GFM, Jonsson AH, Rangel-Moreno J, Meednu N, Rozo C, Apruzzese W, Eisenhaure TM, Lieb DJ, Boyle DL, Mandelin AM 2nd; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium, Boyce BF, DiCarlo E, Gravallese EM, Gregersen PK, Moreland L, Firestein GS, Hacohen N, Nusbaum C, Lederer JA, Perlman H, Pitzalis C, Filer A, Holers VM, Bykerk VP, Donlin LT, Anolik JH, Brenner MB, Raychaudhuri S.

Nat Immunol. 2019 Jul;20(7):928-942. doi: 10.1038/s41590-019-0378-1. Epub 2019 May 6.

PMID:
31061532
9.

Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis.

Chang HH, Ho CH, Tomita B, Silva AA, Sparks JA, Karlson EW, Rao DA, Lee YC, Ho IC.

J Autoimmun. 2019 Jul;101:121-130. doi: 10.1016/j.jaut.2019.04.012. Epub 2019 Apr 26.

PMID:
31030958
10.

Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.

Fatease AA, Shah V, Nguyen DX, Cote B, LeBlanc N, Rao DA, Alani AWG.

Nanomedicine. 2019 Jul;19:39-48. doi: 10.1016/j.nano.2019.03.011. Epub 2019 Apr 22.

PMID:
31022465
11.

Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures.

Reyes M, Vickers D, Billman K, Eisenhaure T, Hoover P, Browne EP, Rao DA, Hacohen N, Blainey PC.

Sci Adv. 2019 Jan 23;5(1):eaau9223. doi: 10.1126/sciadv.aau9223. eCollection 2019 Jan.

12.

Plateletpheresis-associated lymphopenia in frequent platelet donors.

Gansner JM, Rahmani M, Jonsson AH, Fortin BM, Brimah I, Ellis M, Smeland-Wagman R, Li ZJ, Schenkel JM, Brenner MB, Yefidoff-Freedman R, Sloan SR, Berliner N, Issa NC, Baden LR, Longo DL, Wesemann DR, Neuberg D, Rao DA, Kaufman RM.

Blood. 2019 Feb 7;133(6):605-614. doi: 10.1182/blood-2018-09-873125. Epub 2018 Nov 14.

PMID:
30429159
13.

Hepatitis E Virus-Associated Acute Encephalitic Parkinsonism.

Pasha SA, Pasha SA, Suhasini T, Rao DA.

J Assoc Physicians India. 2018 Mar;66(3):92-3.

PMID:
30341882
14.

Discovering in vivo cytokine-eQTL interactions from a lupus clinical trial.

Davenport EE, Amariuta T, Gutierrez-Arcelus M, Slowikowski K, Westra HJ, Luo Y, Shen C, Rao DA, Zhang Y, Pearson S, von Schack D, Beebe JS, Bing N, John S, Vincent MS, Zhang B, Raychaudhuri S.

Genome Biol. 2018 Oct 19;19(1):168. doi: 10.1186/s13059-018-1560-8.

15.

Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer.

Shah VM, Nguyen DX, Al Fatease A, Patel P, Cote B, Woo Y, Gheewala R, Pham Y, Huynh MG, Gannett C, Rao DA, Alani AWG.

J Control Release. 2018 Dec 10;291:169-183. doi: 10.1016/j.jconrel.2018.10.021. Epub 2018 Oct 16.

PMID:
30339904
16.

Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis.

Fonseka CY, Rao DA, Teslovich NC, Korsunsky I, Hannes SK, Slowikowski K, Gurish MF, Donlin LT, Lederer JA, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Todd DJ, Bykerk VP, Karlson EW, Ermann J, Lee YC, Brenner MB, Raychaudhuri S.

Sci Transl Med. 2018 Oct 17;10(463). pii: eaaq0305. doi: 10.1126/scitranslmed.aaq0305.

17.

T Cells That Help B Cells in Chronically Inflamed Tissues.

Rao DA.

Front Immunol. 2018 Aug 23;9:1924. doi: 10.3389/fimmu.2018.01924. eCollection 2018. Review.

18.

Editorial: Lymphocyte Highs and Lows With Baricitinib.

Rao DA.

Arthritis Rheumatol. 2018 Dec;70(12):1897-1900. doi: 10.1002/art.40681. Epub 2018 Oct 15. No abstract available.

PMID:
30058141
19.

Methods for high-dimensonal analysis of cells dissociated from cyropreserved synovial tissue.

Donlin LT, Rao DA, Wei K, Slowikowski K, McGeachy MJ, Turner JD, Meednu N, Mizoguchi F, Gutierrez-Arcelus M, Lieb DJ, Keegan J, Muskat K, Hillman J, Rozo C, Ricker E, Eisenhaure TM, Li S, Browne EP, Chicoine A, Sutherby D, Noma A; Accelerating Medicines Partnership RA/SLE Network, Nusbaum C, Kelly S, Pernis AB, Ivashkiv LB, Goodman SM, Robinson WH, Utz PJ, Lederer JA, Gravallese EM, Boyce BF, Hacohen N, Pitzalis C, Gregersen PK, Firestein GS, Raychaudhuri S, Moreland LW, Holers VM, Bykerk VP, Filer A, Boyle DL, Brenner MB, Anolik JH.

Arthritis Res Ther. 2018 Jul 11;20(1):139. doi: 10.1186/s13075-018-1631-y.

20.

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis.

Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, Nguyen HN, Noss EH, Turner JD, Earp BE, Blazar PE, Wright J, Simmons BP, Donlin LT, Kalliolias GD, Goodman SM, Bykerk VP, Ivashkiv LB, Lederer JA, Hacohen N, Nigrovic PA, Filer A, Buckley CD, Raychaudhuri S, Brenner MB.

Nat Commun. 2018 Feb 23;9(1):789. doi: 10.1038/s41467-018-02892-y.

21.

Optical Coherence Tomography Angiography Vessel Density Measurements in Eyes With Primary Open-Angle Glaucoma and Disc Hemorrhage.

Rao HL, Pradhan ZS, Weinreb RN, Dasari S, Riyazuddin M, Venugopal JP, Puttaiah NK, Rao DAS, Devi S, Mansouri K, Webers CAB.

J Glaucoma. 2017 Oct;26(10):888-895. doi: 10.1097/IJG.0000000000000758.

PMID:
28991833
22.

Leveraging blood and tissue CD4+ T cell heterogeneity at the single cell level to identify mechanisms of disease in rheumatoid arthritis.

Fonseka CY, Rao DA, Raychaudhuri S.

Curr Opin Immunol. 2017 Dec;49:27-36. doi: 10.1016/j.coi.2017.08.005. Epub 2017 Sep 6. Review.

23.

Repeatability of vessel density measurements of optical coherence tomography angiography in normal and glaucoma eyes.

Venugopal JP, Rao HL, Weinreb RN, Pradhan ZS, Dasari S, Riyazuddin M, Puttiah NK, Rao DAS, Devi S, Mansouri K, Webers CA.

Br J Ophthalmol. 2018 Mar;102(3):352-357. doi: 10.1136/bjophthalmol-2017-310637. Epub 2017 Jul 24.

PMID:
28739645
24.

Relationship of Optic Nerve Structure and Function to Peripapillary Vessel Density Measurements of Optical Coherence Tomography Angiography in Glaucoma.

Rao HL, Pradhan ZS, Weinreb RN, Dasari S, Riyazuddin M, Raveendran S, Puttaiah NK, Venugopal JP, Rao DAS, Devi S, Mansouri K, Webers CAB.

J Glaucoma. 2017 Jun;26(6):548-554. doi: 10.1097/IJG.0000000000000670.

PMID:
28333896
25.

A comparison of the diagnostic ability of vessel density and structural measurements of optical coherence tomography in primary open angle glaucoma.

Rao HL, Pradhan ZS, Weinreb RN, Riyazuddin M, Dasari S, Venugopal JP, Puttaiah NK, Rao DA, Devi S, Mansouri K, Webers CA.

PLoS One. 2017 Mar 13;12(3):e0173930. doi: 10.1371/journal.pone.0173930. eCollection 2017.

26.

Vessel Density and Structural Measurements of Optical Coherence Tomography in Primary Angle Closure and Primary Angle Closure Glaucoma.

Rao HL, Pradhan ZS, Weinreb RN, Riyazuddin M, Dasari S, Venugopal JP, Puttaiah NK, Rao DAS, Devi S, Mansouri K, Webers CAB.

Am J Ophthalmol. 2017 May;177:106-115. doi: 10.1016/j.ajo.2017.02.020. Epub 2017 Feb 28.

PMID:
28254626
27.

Predicting the Magnitude of Functional and Structural Damage in Glaucoma From Monocular Pupillary Light Responses Using Automated Pupillography.

Pradhan ZS, Rao HL, Puttaiah NK, Kadambi SV, Dasari S, Reddy HB, Palakurthy M, Riyazuddin M, Rao DAS.

J Glaucoma. 2017 May;26(5):409-414. doi: 10.1097/IJG.0000000000000634.

PMID:
28169921
28.

Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.

Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB.

Nature. 2017 Feb 1;542(7639):110-114. doi: 10.1038/nature20810.

29.

Bacterial contamination and stethoscope disinfection practices: a cross-sectional survey of healthcare workers in Karachi, Pakistan.

Rao DA, Aman A, Muhammad Mubeen S, Shah A.

Trop Doct. 2017 Jul;47(3):226-230. doi: 10.1177/0049475516686543. Epub 2017 Jan 12.

PMID:
28081676
30.

Comparing the Performance of Compass Perimetry With Humphrey Field Analyzer in Eyes With Glaucoma.

Rao HL, Raveendran S, James V, Dasari S, Palakurthy M, Reddy HB, Pradhan ZS, Rao DA, Puttaiah NK, Devi S.

J Glaucoma. 2017 Mar;26(3):292-297. doi: 10.1097/IJG.0000000000000609.

PMID:
27977480
31.

Diagnostic ability of peripapillary vessel density measurements of optical coherence tomography angiography in primary open-angle and angle-closure glaucoma.

Rao HL, Kadambi SV, Weinreb RN, Puttaiah NK, Pradhan ZS, Rao DAS, Kumar RS, Webers CAB, Shetty R.

Br J Ophthalmol. 2017 Aug;101(8):1066-1070. doi: 10.1136/bjophthalmol-2016-309377. Epub 2016 Nov 29.

PMID:
27899368
32.

Diagnostic Ability of Automated Pupillography in Glaucoma.

Rao HL, Kadambi SV, Mehta P, Dasari S, Puttaiah NK, Pradhan ZS, Rao DAS, Shetty R.

Curr Eye Res. 2017 May;42(5):743-747. doi: 10.1080/02713683.2016.1238944. Epub 2016 Nov 29.

PMID:
27897448
33.

Predicting the intereye asymmetry in functional and structural damage in glaucoma using automated pupillography.

Rao HL, Kadambi SV, Dasari S, Reddy HB, Palakurthy M, Riyazuddin M, Puttaiah NK, Pradhan ZS, Rao DAS, Shetty R.

Acta Ophthalmol. 2017 Nov;95(7):e532-e538. doi: 10.1111/aos.13317. Epub 2016 Nov 22.

34.

A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22.

Chang HH, Liu GY, Dwivedi N, Sun B, Okamoto Y, Kinslow JD, Deane KD, Demoruelle MK, Norris JM, Thompson PR, Sparks JA, Rao DA, Karlson EW, Hung HC, Holers VM, Ho IC.

JCI Insight. 2016 Oct 20;1(17):e90045. doi: 10.1172/jci.insight.90045.

35.

Regional Comparisons of Optical Coherence Tomography Angiography Vessel Density in Primary Open-Angle Glaucoma.

Rao HL, Pradhan ZS, Weinreb RN, Reddy HB, Riyazuddin M, Dasari S, Palakurthy M, Puttaiah NK, Rao DA, Webers CA.

Am J Ophthalmol. 2016 Nov;171:75-83. doi: 10.1016/j.ajo.2016.08.030. Epub 2016 Aug 30.

PMID:
27590118
36.

Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells.

Orent W, Mchenry AR, Rao DA, White C, Klein HU, Bassil R, Srivastava G, Replogle JM, Raj T, Frangieh M, Cimpean M, Cuerdon N, Chibnik L, Khoury SJ, Karlson EW, Brenner MB, De Jager P, Bradshaw EM, Elyaman W.

Hum Mol Genet. 2016 Jan 15;25(2):404-17. doi: 10.1093/hmg/ddv474. Epub 2015 Nov 24.

37.

A three-drug nanoscale drug delivery system designed for preferential lymphatic uptake for the treatment of metastatic melanoma.

Doddapaneni BS, Kyryachenko S, Chagani SE, Alany RG, Rao DA, Indra AK, Alani AWG.

J Control Release. 2015 Dec 28;220(Pt A):503-514. doi: 10.1016/j.jconrel.2015.11.013. Epub 2015 Nov 11.

PMID:
26578440
38.

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles.

Rao DA, Nguyen DX, Mishra GP, Doddapaneni BS, Alani AW.

J Vis Exp. 2015 Aug 28;(102):e53047. doi: 10.3791/53047.

39.

Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.

Cote B, Carlson LJ, Rao DA, Alani AWG.

J Control Release. 2015 Sep 10;213:128-133. doi: 10.1016/j.jconrel.2015.06.040. Epub 2015 Jul 6.

PMID:
26160305
40.

Immune cell profiling to guide therapeutic decisions in rheumatic diseases.

Ermann J, Rao DA, Teslovich NC, Brenner MB, Raychaudhuri S.

Nat Rev Rheumatol. 2015 Sep;11(9):541-51. doi: 10.1038/nrrheum.2015.71. Epub 2015 Jun 2. Review.

41.

Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.

Rao DA, Wei K, Merola JF, O'Brien WR, Takvorian SU, Dellaripa PF, Schur PH.

J Rheumatol. 2015 May;42(5):847-52. doi: 10.3899/jrheum.140941. Epub 2015 Apr 1.

42.
43.

Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.

Carlson LJ, Cote B, Alani AW, Rao DA.

J Pharm Sci. 2014 Aug;103(8):2315-22. doi: 10.1002/jps.24042. Epub 2014 Jun 9.

PMID:
24914015
44.

Clinical problem-solving. In the thick of it.

Rao DA, Lakdawala NK, Miller AL, Loscalzo J.

N Engl J Med. 2013 May 2;368(18):1732-8. doi: 10.1056/NEJMcps1209279. No abstract available. Erratum in: N Engl J Med. 2013 Jul 18;369(3):293.

PMID:
23635054
45.

Extrapulmonary manifestations of sarcoidosis.

Rao DA, Dellaripa PF.

Rheum Dis Clin North Am. 2013 May;39(2):277-97. doi: 10.1016/j.rdc.2013.02.007. Epub 2013 Mar 13. Review.

46.

Platelets signal and tumors take off.

Rao AK, Rao DA.

Blood. 2012 Dec 6;120(24):4667-8. doi: 10.1182/blood-2012-09-457325. No abstract available.

47.

Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.

Fogal B, Yi T, Wang C, Rao DA, Lebastchi A, Kulkarni S, Tellides G, Pober JS.

J Immunol. 2011 Dec 15;187(12):6268-80. doi: 10.4049/jimmunol.1003774. Epub 2011 Nov 14.

48.

Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model.

Yi T, Fogal B, Hao Z, Tobiasova Z, Wang C, Rao DA, Al-Lamki RS, Kirkiles-Smith NC, Kulkarni S, Bradley JR, Bothwell AL, Sessa WC, Tellides G, Pober JS.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):353-60. doi: 10.1161/ATVBAHA.111.239285. Epub 2011 Nov 3.

49.

Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells.

Lebastchi AH, Khan SF, Qin L, Li W, Zhou J, Hibino N, Yi T, Rao DA, Pober JS, Tellides G.

Am J Transplant. 2011 Nov;11(11):2332-41. doi: 10.1111/j.1600-6143.2011.03676.x. Epub 2011 Aug 3.

50.

Drug loading in Pluronic® micelles made by solvent casting and equilibrium methods using resveratrol as a model drug.

Stammet M, Kwon GS, Rao DA.

J Control Release. 2010 Nov 20;148(1):e50-1. doi: 10.1016/j.jconrel.2010.07.056. No abstract available.

PMID:
21529622

Supplemental Content

Support Center